These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 10636)

  • 1. Purification and properties of human factor IXa.
    Váradi K; Elödi S
    Thromb Haemost; 1976 Jun; 35(3):576-85. PubMed ID: 10636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of human factor IX by chromatography of a coagulation factor concentrate.
    Suomela H
    Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.
    Chung KS; Madar DA; Goldsmith JC; Kingdon HS; Roberts HR
    J Clin Invest; 1978 Nov; 62(5):1078-85. PubMed ID: 711853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihaemophilic factor (factor VIII) from human granulocytes.
    Szmitkowski M; Prokopowicz J; Szmitkowska K
    Haematologia (Budap); 1977; 11(1-2):177-87. PubMed ID: 27427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
    Luben RA; Mundy GR; Trummel CL; Raisz LG
    J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
    Takahashi I; Kato K; Sugiura I; Takamatsu J; Kamiya T; Saito H
    J Lab Clin Med; 1991 Oct; 118(4):317-25. PubMed ID: 1940573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation of human factor IX.
    Osterud B; Laake K; Prydz H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):553-63. PubMed ID: 239460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Purification and some physico-chemical and enzymatic properties of tissue kallikrein from human urine].
    Rabinovich SE; Lobareva LS; Paskhina TS
    Biokhimiia; 1990 Sep; 55(9):1675-89. PubMed ID: 2078641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and heat-treatment of factor-IX-concentrates.
    Stampe D; Wieland B; Köhle A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):523-7. PubMed ID: 2465966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on thiamine diphosphate kinase (EC 2.7.4.15) from brewer's yeast: purification and some properties.
    Voskoboyev AI; Chernikevich IP; Luchko VS
    Biomed Biochim Acta; 1987; 46(1):3-13. PubMed ID: 3034239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro mutagenesis study of two critical glutamic acids in the calcium binding loop of the factor IX heavy chain.
    Hamaguchi N; Stafford D
    Thromb Haemost; 1994 Dec; 72(6):856-61. PubMed ID: 7740454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T; Michalski C; Goudemand M; Huart JJ
    Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification and some properties of pyroglutamyl peptidase from Enterococcus faecalis.
    Mineyama R; Saito K
    Microbios; 1998; 94(377):47-62. PubMed ID: 9785485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y; Boyeldieu D; Stieltjes N
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human factor IXa by human antithrombin.
    Rosenberg JS; McKenna PW; Rosenberg RD
    J Biol Chem; 1975 Dec; 250(23):8883-8. PubMed ID: 1194266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography.
    Feldman PA; Bradbury PI; Williams JD; Sims GE; McPhee JW; Pinnell MA; Harris L; Crombie GI; Evans DR
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):939-48. PubMed ID: 7893930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of an active substance responsible for the factor VIII inhibitor bypassing activity in Autoplex.
    Fukui H; Fujimura Y; Sugimoto M; Okubo Y; Yoshioka A
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):134-46. PubMed ID: 3873774
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification and characterization of rabbit factor IX and its existence as a two-chain factor IX alpha in circulating plasma.
    Rao LV; Hoang AD
    Thromb Res; 1991 Oct; 64(1):57-68. PubMed ID: 1776139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.